FDA Adverse Event Malfunction Summary report: N

PAXGENE® BLOOD RNA TUBE

MDR report key: 8575851 · Received May 2, 2019

Report

Report Number
9617032-2019-00539
Event Type
Malfunction
Date Received
May 2, 2019
Date of Event
April 10, 2019
Report Date
May 23, 2019
Manufacturer
BECTON, DICKINSON AND COMPANY (BD)
Product Code
NTW
PMA / PMN Number
DEN050003
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
DE, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION: INVESTIGATION SUMMARY: BD RECEIVED SAMPLES FROM THE CUSTOMER FACILITY FOR INVESTIGATION. THE SAMPLES WERE TESTED/EVALUATED AND THE CUSTOMER'S INDICATED FAILURE MODE FOR GLASS BREAKAGE WITH THE INCIDENT LOT WAS NOT OBSERVED AS ALL PRODUCT SPECIFICATIONS WERE MET. A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED FOR THE INCIDENT LOT AND, BASED ON THIS REVIEW, ALL PRODUCT SPECIFICATIONS AND REQUIREMENTS FOR LOT RELEASE WERE MET; THERE WERE NO RELATED QUALITY NON-CONFORMANCES DURING MANUFACTURING OF THE PRODUCT. INVESTIGATION CONCLUSION: BASED ON EVALUATION OF THE CUSTOMER SAMPLES, THE CUSTOMER¿S INDICATED FAILURE MODE FOR GLASS BREAKAGE WITH THE INCIDENT LOT WAS NOT OBSERVED AS ALL SAMPLES MET THE REQUIRED SPECIFICATIONS. ROOT CAUSE DESCRIPTION: BASED ON THE INVESTIGATION, A ROOT CAUSE COULD NOT BE DETERMINED. THE PRODUCT WAS FOUND TO BE IN CONFORMANCE AND MEET RELEASE SPECIFICATIONS. RATIONALE: COMPLAINTS RECEIVED FOR THIS DEVICE AND REPORTED CONDITION WILL CONTINUE TO BE TRACKED AND TRENDED. INFORMATION WILL BE CAPTURED ON TREND REPORTS AND MONITORED. THE BD BUSINESS TEAM REGULARLY REVIEWS THE COLLECTED DATA FOR IDENTIFICATION OF EMERGING TRENDS.

Description of Event or Problem · 0

IT WAS REPORTED THAT 40 PAXGENE® BLOOD RNA TUBE EXPERIENCED GLASS BREAKAGE DURING USE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO. 762165, BATCH NO. 8081587. RCVD CALL FROM: CUST STATED SHE IS EXPERIENCING CRACKING OF TUBES AFTER USE, WORKERS WERE EXPOSED TO BLOOD BUT NO TESTING WAS DONE. CUSTOMER DOES HAVE PHOTOS SHE WILL EMAIL AS WELL AS PRODUCTS TO SEND OUT WHEN SHE RCVS FEDEX LABELS. THERE WAS 2 DATES OF OCCURRENCES (B)(6) 2019 (20) AND (B)(6) 2019 (40). SAME INFORMATION FOR BOTH DATES.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION IS ANTICIPATED, BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT WAS REPORTED THAT 40 PAXGENE® BLOOD RNA TUBE EXPERIENCED GLASS BREAKAGE DURING USE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MATERIAL NO. 762165, BATCH NO. 8081587. RCVD CALL FROM: CUST STATED SHE IS EXPERIENCING CRACKING OF TUBES AFTER USE, WORKERS WERE EXPOSED TO BLOOD BUT NO TESTING WAS DONE. CUSTOMER DOES HAVE PHOTOS SHE WILL EMAIL AS WELL AS PRODUCTS TO SEND OUT WHEN SHE RCVS (B)(6) LABELS. THERE WAS 2 DATES OF OCCURRENCES (B)(6) 2019 (20) AND (B)(6) 2019 (40). SAME INFORMATION FOR BOTH DATES.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
369625 PAXGENE® BLOOD RNA TUBE RNA PREANALYTICAL SYSTEMS NTW BECTON, DICKINSON AND COMPANY (BD) 8081587

Patients

Seq Age Sex Outcome Treatment
1 Other